Scarica l'app Stockscreener
21.54
9.84%
1.93
Precedente Chiudi:
$19.61
Aprire:
$19.61
Volume 24 ore:
108.35K
Relative Volume:
3.03
Capitalizzazione di mercato:
$191.76M
Reddito:
$64.99M
Utile/perdita netta:
$-4.30M
Rapporto P/E:
-41.42
EPS:
-0.52
Flusso di cassa netto:
$-3.51M
1 W Prestazione:
-22.28%
1M Prestazione:
-28.10%
6M Prestazione:
-31.18%
1 anno Prestazione:
-40.17%
Intervallo 1D:
$19.52
$22.65
Intervallo di 1 settimana:
$19.10
$29.20
Portata 52W:
$19.10
$38.75
Sanara Medtech Inc Stock (SMTI) Company Profile
Nome
Sanara Medtech Inc
Settore
Industria
Telefono
817-529-2300
Indirizzo
1200 SUMMIT AVE, FORT WORTH
Confronta SMTI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
21.54 | 175.23M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2024-12-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-20 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Borsa (SMTI) Ultime notizie
Sanara MedTech (SMTI) Receives Updated Analyst Rating and Price Target | SMTI Stock News - GuruFocus
Can Sanara MedTech Inc. stock rebound after recent weaknessTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Is Sanara MedTech Inc. stock gaining market shareMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
HC Wainwright & Co. Maintains Sanara MedTech (SMTI) Buy Recommendation - Nasdaq
Can Sanara MedTech Inc. stock sustain revenue growthMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Best data tools to analyze Sanara MedTech Inc. stockTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Sanara MedTech Hits 52-Week Low at USD 21.07 Amid Ongoing Struggles - Markets Mojo
How strong is Sanara MedTech Inc. stock revenue growthJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Sanara MedTech (SMTI): Assessing Valuation After Strategic Shift and Quarterly Earnings Beat - Yahoo Finance
Can Sanara MedTech Inc. stock deliver consistent earnings growth2025 Market Overview & Fast Moving Trade Plans - newser.com
Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2025 Earnings Call Transcript - MSN
Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted? - simplywall.st
Visualizing Sanara MedTech Inc. stock with heatmapsJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Sanara MedTech Reports Strong Q3 2025 Growth - TipRanks
Identifying reversal signals in Sanara MedTech Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
[10-Q] Sanara MedTech Inc. Quarterly Earnings Report | SMTI SEC FilingForm 10-Q - Stock Titan
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Earnings call transcript: Sanara MedTech Q3 2025 sees revenue growth, stock up 3.1% - Investing.com Nigeria
Sanara MedTech Q3 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Inc. Initiates Strategic Realignment of its Business, Discontinuing Operations of its Tissue Health Plus - MarketScreener
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus - MSN
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - Yahoo Finance
Sanara Medtech Bets On Core Surgery After Mixed Q3 Results - Finimize
SMTI Posts Strong Q3 Revenue Growth Driven by Surgical Sales - GuruFocus
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure - MarketScreener
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) - The Manila Times
[8-K] Sanara MedTech Inc. Reports Material Event | SMTI SEC FilingForm 8-K - Stock Titan
Sanara MedTech to Discontinue Tissue Health Plus Operations After Review - MarketScreener
Sanara MedTech (SMTI) Realigns Focus by Discontinuing THP Operat - GuruFocus
Sanara MedTech discontinues Tissue Health Plus segment - Investing.com
Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations - Quiver Quantitative
Sanara MedTech (NASDAQ: SMTI) to classify THP as discontinued ops, wind-down through 2025 - Stock Titan
What To Expect From Sanara MedTech Inc (SMTI) Q3 2025 Earnings - GuruFocus
Sanara MedTech (SMTI) to Release Earnings on Wednesday - Defense World
Sanara MedTech showcases BIASURGE at TERMIS 2025 in Detroit - Traders Union
Sanara MedTech Inc. stock momentum explainedPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com
What valuation multiples suggest for Sanara MedTech Inc. stockWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Sanara Medtech Inc Azioni (SMTI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):